These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27582542)

  • 21. Benzyl isothiocyanate (BITC) induces G2/M phase arrest and apoptosis in human melanoma A375.S2 cells through reactive oxygen species (ROS) and both mitochondria-dependent and death receptor-mediated multiple signaling pathways.
    Huang SH; Wu LW; Huang AC; Yu CC; Lien JC; Huang YP; Yang JS; Yang JH; Hsiao YP; Wood WG; Yu CS; Chung JG
    J Agric Food Chem; 2012 Jan; 60(2):665-75. PubMed ID: 22148415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human melanoma growth by a non-cardioselective β-blocker.
    Wrobel LJ; Le Gal FA
    J Invest Dermatol; 2015 Feb; 135(2):525-531. PubMed ID: 25178102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moxidectin inhibits glioma cell viability by inducing G0/G1 cell cycle arrest and apoptosis.
    Song D; Liang H; Qu B; Li Y; Liu J; Chen C; Zhang D; Zhang X; Gao A
    Oncol Rep; 2018 Sep; 40(3):1348-1358. PubMed ID: 30015956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of SOCS1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study.
    Yu SJ; Long ZW
    Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway.
    Ming P; Cai T; Li J; Ning Y; Xie S; Tao T; Tang F
    Oncotarget; 2016 Jul; 7(27):41843-41856. PubMed ID: 27259234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo anti-tumor activity of CoQ0 against melanoma cells: inhibition of metastasis and induction of cell-cycle arrest and apoptosis through modulation of Wnt/β-catenin signaling pathways.
    Hseu YC; Thiyagarajan V; Tsou HT; Lin KY; Chen HJ; Lin CM; Liao JW; Yang HL
    Oncotarget; 2016 Apr; 7(16):22409-26. PubMed ID: 26968952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A DC-81-indole conjugate agent suppresses melanoma A375 cell migration partially via interrupting VEGF production and stromal cell-derived factor-1α-mediated signaling.
    Hsieh MC; Hu WP; Yu HS; Wu WC; Chang LS; Kao YH; Wang JJ
    Toxicol Appl Pharmacol; 2011 Sep; 255(2):150-9. PubMed ID: 21708181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells.
    Huang WW; Yang JS; Pai SJ; Wu PP; Chang SJ; Chueh FS; Fan MJ; Chiou SM; Kuo HM; Yeh CC; Chen PY; Tsuzuki M; Chung JG
    Mutat Res; 2012 Apr; 732(1-2):26-33. PubMed ID: 22285700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling.
    Liao X; Che X; Zhao W; Zhang D; Bi T; Wang G
    Oncol Rep; 2010 Dec; 24(6):1669-76. PubMed ID: 21042766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic drug tigecycline reduces neuroblastoma cells proliferation by inhibiting Akt activation in vitro and in vivo.
    Zhong X; Zhao E; Tang C; Zhang W; Tan J; Dong Z; Ding HF; Cui H
    Tumour Biol; 2016 Jun; 37(6):7615-23. PubMed ID: 26687647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Juniperus indica Bertol. extract synergized with cisplatin against melanoma cells via the suppression of AKT/mTOR and MAPK signaling and induction of cell apoptosis.
    Huang XF; Gao HW; Lee SC; Chang KF; Tang LT; Tsai NM
    Int J Med Sci; 2021; 18(1):157-168. PubMed ID: 33390784
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
    Montoya A; Amaya CN; Belmont A; Diab N; Trevino R; Villanueva G; Rains S; Sanchez LA; Badri N; Otoukesh S; Khammanivong A; Liss D; Baca ST; Aguilera RJ; Dickerson EB; Torabi A; Dwivedi AK; Abbas A; Chambers K; Bryan BA; Nahleh Z
    Oncotarget; 2017 Jan; 8(4):6446-6460. PubMed ID: 28031536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells.
    Airiau K; Prouzet-Mauléon V; Rousseau B; Pigneux A; Jeanneteau M; Giraudon M; Allou K; Dubus P; Belloc F; Mahon FX
    Oncotarget; 2016 Jan; 7(1):845-59. PubMed ID: 26625317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.
    Zhao Y; Wang X; Sun Y; Zhou Y; Yin Y; Ding Y; Li Z; Guo Q; Lu N
    Apoptosis; 2015 Sep; 20(9):1253-69. PubMed ID: 26153346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Mcl-1 confers resistance to BRAFV600E inhibitors alone and in combination with MEK1/2 inhibitors in melanoma.
    Fofaria NM; Frederick DT; Sullivan RJ; Flaherty KT; Srivastava SK
    Oncotarget; 2015 Dec; 6(38):40535-56. PubMed ID: 26497853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trifluoperazine Inhibits Mesangial Cell Proliferation by Arresting Cell Cycle-Dependent Mechanisms.
    Wang B; Zhou X; Wang Y; Li R
    Med Sci Monit; 2017 Jul; 23():3461-3469. PubMed ID: 28713151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer.
    Zhu Y; Tian T; Zou J; Wang Q; Li Z; Li Y; Liu X; Dong B; Li N; Gao J; Shen L
    BMC Cancer; 2015 Nov; 15():894. PubMed ID: 26560145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The herbal medicine Cyperus amuricus inhibits proliferation of human hepatocellular carcinoma Hep3B cells by inducing apoptosis and arrest at the G0/G1 cell cycle phase.
    Pham HH; Seong YA; Oh CW; Kim GD
    Int J Oncol; 2016 Nov; 49(5):2046-2054. PubMed ID: 27667556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.
    Cholewa BD; Ndiaye MA; Huang W; Liu X; Ahmad N
    Cancer Lett; 2017 Jan; 385():179-187. PubMed ID: 27793694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-clinical assessment of A-674563 as an anti-melanoma agent.
    Zou Y; Fan G; Wang X
    Biochem Biophys Res Commun; 2016 Aug; 477(1):1-8. PubMed ID: 26970307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.